Page last updated: 2024-09-03

y 26763 and sphingosine

y 26763 has been researched along with sphingosine in 1 studies

Compound Research Comparison

Studies
(y 26763)
Trials
(y 26763)
Recent Studies (post-2010)
(y 26763)
Studies
(sphingosine)
Trials
(sphingosine)
Recent Studies (post-2010) (sphingosine)
33048,3251173,459

Protein Interaction Comparison

ProteinTaxonomyy 26763 (IC50)sphingosine (IC50)
ubiquitin-conjugating enzyme E2 NHomo sapiens (human)6.3125
cAMP-dependent protein kinase catalytic subunit alpha Rattus norvegicus (Norway rat)0.098
Sphingosine kinase 2Homo sapiens (human)1.56
Sphingosine kinase 1Homo sapiens (human)3.86

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujisawa, H; Kobayashi, S; Kudo, A; Kunitsugu, I; Kurokawa, T; Ogasawara, K; Ogawa, A; Shirao, S; Soma, M; Suzuki, M; Yoneda, H1

Other Studies

1 other study(ies) available for y 26763 and sphingosine

ArticleYear
Inhibitory effects of eicosapentaenoic acid on chronic cerebral vasospasm after subarachnoid hemorrhage: possible involvement of a sphingosylphosphorylcholine-rho-kinase pathway.
    Cerebrovascular diseases (Basel, Switzerland), 2008, Volume: 26, Issue:1

    Topics: Animals; Basilar Artery; Benzopyrans; Cerebral Angiography; Cisterna Magna; Disease Models, Animal; Dogs; Eicosapentaenoic Acid; Female; Injections; Male; Phosphorylcholine; Protein Kinase Inhibitors; rho-Associated Kinases; Signal Transduction; Sphingosine; Subarachnoid Hemorrhage; Time Factors; Vasoconstriction; Vasodilator Agents; Vasospasm, Intracranial

2008
chemdatabank.com